TerminatedPhase 4

Bloodtranfusions After Aortic Surgery

Stopped: Slow inclusion

Netherlands27 participantsStarted 2014-08-01

Plain-language summary

The purpose of this study is to answer the following question: Leads a primary coagulation corrected with a single dose of fibrinogen concentrate after ascending aorta-arc reconstruction to a decrease in the number of allogenic blood transfusions, compared to placebo?

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Elective surgery for thoracic aneurysm Exclusion Criteria: * Prior trombosis or myocardial infarction, congenital coagulation disorder, use of anti-coagulants prior to surgery, prior thoracic surgery, pregnancy, pre-operative fibrinogen concentration \<1g/L

What they're measuring

Number of transfused blood products

Timeframe: 24 hours after surgery

Trial details

NCT IDNCT02299947

SponsorSt. Antonius Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-04-26

View on ClinicalTrials.gov More Hemorrhage trials